Quoin Pharmaceuticals Ltd ADR (QNRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 2,125 | 2,260 | 2,776 | 2,086 | 2,328 |
| Operating Income | -2,125 | -2,260 | -2,776 | -2,086 | -2,328 |
| Interest Expense | 0 | 0 | 0 | 0 | 714 |
| Other Income | 199 | 153 | 173 | 85 | 12 |
| Pre-tax Income | -1,927 | -2,107 | -2,603 | -2,001 | -3,030 |
| Net Income Continuous | -1,927 | -2,107 | -2,603 | -2,001 | -3,030 |
| Net Income | $-1,927 | $-2,107 | $-2,603 | $-2,001 | $-3,030 |
| EPS Basic Total Ops | -68.18 | -74.48 | -143.01 | 1,171.75 | -394.41 |
| EPS Basic Continuous Ops | -68.25 | -74.64 | -142.83 | 1,174.16 | -386.16 |
| EPS Diluted Total Ops | -68.18 | -74.48 | -143.01 | 1,171.75 | -394.41 |
| EPS Diluted Continuous Ops | -68.25 | -74.64 | -142.83 | 1,174.16 | -386.16 |
| EBITDA(a) | $-2,099 | $-2,234 | $-2,750 | $-2,060 | $-2,302 |